Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
type: MedicalStudy
description: Long-term Study of Immune Response Persistence of GSK Biologicals' 2-dose Thiomersal-free Engerix™-B and 3-dose Preservative-free Engerix™-B Vaccines in Subjects Aged 11-15 Yrs
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2004-04-21
end date: 2008-01-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00343915
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: GlaxoSmithKline
study subject: Hepatitis B
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Hepatitis B

AI Analytics
type: Organization